Report Detail

Other Global Prostate-Specific Antigen (PSA) Test Market Size, Status and Forecast 2021-2027

  • RnM3199578
  • |
  • 19 January, 2021
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Prostate-Specific Antigen (PSA) Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-Specific Antigen (PSA) Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CLIA
ELISA
Other

Segment by Application
Screening
Post-treatment Monitoring
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Roche


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 CLIA
    • 1.2.3 ELISA
    • 1.2.4 Other
  • 1.3 Market by Application
    • 1.3.1 Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Screening
    • 1.3.3 Post-treatment Monitoring
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2016-2027)
  • 2.2 Prostate-Specific Antigen (PSA) Test Growth Trends by Regions
    • 2.2.1 Prostate-Specific Antigen (PSA) Test Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Share by Regions (2016-2021)
    • 2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Regions (2022-2027)
  • 2.3 Prostate-Specific Antigen (PSA) Test Industry Dynamic
    • 2.3.1 Prostate-Specific Antigen (PSA) Test Market Trends
    • 2.3.2 Prostate-Specific Antigen (PSA) Test Market Drivers
    • 2.3.3 Prostate-Specific Antigen (PSA) Test Market Challenges
    • 2.3.4 Prostate-Specific Antigen (PSA) Test Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue
    • 3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2016-2021)
    • 3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2016-2021)
  • 3.2 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue
  • 3.4 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio
    • 3.4.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2020
  • 3.5 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served
  • 3.6 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service
  • 3.7 Date of Enter into Prostate-Specific Antigen (PSA) Test Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate-Specific Antigen (PSA) Test Breakdown Data by Type

  • 4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2016-2021)
  • 4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2022-2027)

5 Prostate-Specific Antigen (PSA) Test Breakdown Data by Application

  • 5.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Application (2016-2021)
  • 5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2016-2027)
  • 6.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Type
    • 6.2.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2021)
    • 6.2.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2022-2027)
    • 6.2.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2027)
  • 6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Application
    • 6.3.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2021)
    • 6.3.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2022-2027)
    • 6.3.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2027)
  • 6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Country
    • 6.4.1 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2016-2021)
    • 6.4.2 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2016-2027)
  • 7.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type
    • 7.2.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2021)
    • 7.2.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2022-2027)
    • 7.2.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2027)
  • 7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application
    • 7.3.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2021)
    • 7.3.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2022-2027)
    • 7.3.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2027)
  • 7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country
    • 7.4.1 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2016-2021)
    • 7.4.2 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size (2016-2027)
  • 8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type
    • 8.2.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application
    • 8.3.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region
    • 8.4.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size (2016-2027)
  • 9.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type
    • 9.2.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2021)
    • 9.2.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2022-2027)
    • 9.2.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2027)
  • 9.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application
    • 9.3.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2021)
    • 9.3.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2022-2027)
    • 9.3.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2027)
  • 9.4 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country
    • 9.4.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2016-2021)
    • 9.4.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size (2016-2027)
  • 10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type
    • 10.2.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application
    • 10.3.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country
    • 10.4.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott
    • 11.1.1 Abbott Company Details
    • 11.1.2 Abbott Business Overview
    • 11.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction
    • 11.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.1.5 Abbott Recent Development
  • 11.2 Siemens Healthcare
    • 11.2.1 Siemens Healthcare Company Details
    • 11.2.2 Siemens Healthcare Business Overview
    • 11.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction
    • 11.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.2.5 Siemens Healthcare Recent Development
  • 11.3 DiaSorin
    • 11.3.1 DiaSorin Company Details
    • 11.3.2 DiaSorin Business Overview
    • 11.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction
    • 11.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.3.5 DiaSorin Recent Development
  • 11.4 Roche
    • 11.4.1 Roche Company Details
    • 11.4.2 Roche Business Overview
    • 11.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction
    • 11.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.4.5 Roche Recent Development
  • 11.5 Beckman Coulter
    • 11.5.1 Beckman Coulter Company Details
    • 11.5.2 Beckman Coulter Business Overview
    • 11.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction
    • 11.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.5.5 Beckman Coulter Recent Development
  • 11.6 PerkinElmer
    • 11.6.1 PerkinElmer Company Details
    • 11.6.2 PerkinElmer Business Overview
    • 11.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction
    • 11.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.6.5 PerkinElmer Recent Development
  • 11.7 Tosoh
    • 11.7.1 Tosoh Company Details
    • 11.7.2 Tosoh Business Overview
    • 11.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction
    • 11.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.7.5 Tosoh Recent Development
  • 11.8 Ortho Clinical
    • 11.8.1 Ortho Clinical Company Details
    • 11.8.2 Ortho Clinical Business Overview
    • 11.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction
    • 11.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.8.5 Ortho Clinical Recent Development
  • 11.9 Fujirebio
    • 11.9.1 Fujirebio Company Details
    • 11.9.2 Fujirebio Business Overview
    • 11.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction
    • 11.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.9.5 Fujirebio Recent Development
  • 11.10 Mediwatch (LABORIE)
    • 11.10.1 Mediwatch (LABORIE) Company Details
    • 11.10.2 Mediwatch (LABORIE) Business Overview
    • 11.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction
    • 11.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.10.5 Mediwatch (LABORIE) Recent Development
  • 11.11 BodiTech
    • 11.11.1 BodiTech Company Details
    • 11.11.2 BodiTech Business Overview
    • 11.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction
    • 11.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2016-2021)
    • 11.11.5 BodiTech Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Prostate-Specific Antigen (PSA) Test . Industry analysis & Market Report on Prostate-Specific Antigen (PSA) Test is a syndicated market report, published as Global Prostate-Specific Antigen (PSA) Test Market Size, Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Prostate-Specific Antigen (PSA) Test market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,131.70
    4,697.55
    6,263.40
    3,662.10
    5,493.15
    7,324.20
    602,706.00
    904,059.00
    1,205,412.00
    325,962.00
    488,943.00
    651,924.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report